The Sickle Cell Disease Ontology: Enabling Collaborative Research and Co-Designing of New Planetary Health Applications.

Global Clinical Trial Design Sickle Africa Data Coordinating Center SickleInAfrica data harmonization planetary health sickle cell disease sickle cell disease ontology

Journal

Omics : a journal of integrative biology
ISSN: 1557-8100
Titre abrégé: OMICS
Pays: United States
ID NLM: 101131135

Informations de publication

Date de publication:
10 2020
Historique:
entrez: 6 10 2020
pubmed: 7 10 2020
medline: 31 7 2021
Statut: ppublish

Résumé

Sickle cell disease (SCD) is one of the most common blood disorders impacting planetary health. Over 300,000 newborns are diagnosed with SCD each year globally, with an increasing trend. The sickle cell disease ontology (SCDO) is the most comprehensive multidisciplinary SCD knowledge portal. The SCDO was collaboratively developed by the SCDO working group, which includes experts in SCD and data standards from across the globe. This expert review presents highlights and lessons learned from the fourth SCDO workshop that marked the beginning of applications toward planetary health impact, and with an eye to empower and cultivate multisite SCD collaborative research. The workshop was organized by the Sickle Africa Data Coordinating Center (SADaCC) and attended by 44 participants from 14 countries, with 2 participants connecting remotely. Notably, from the standpoint of democratizing and innovating scientific meeting design, an SCD patient advocate also presented at the workshop, giving a broader real-life perspective on patients' aspirations, needs, and challenges. A major component of the workshop was new approaches to harness SCDO to harmonize data elements used by different studies. This was facilitated by a web-based platform onto which participants uploaded data elements from previous or ongoing SCD-relevant research studies before the workshop, making multisite collaborative research studies based on existing SCD data possible, including multisite cohort, SCD global clinical trials, and SCD community engagement approaches. Trainees presented proposals for systematic literature reviews in key SCD research areas. This expert review emphasizes potential and prospects of SCDO-enabled data standards and harmonization to facilitate large-scale global SCD collaborative initiatives. As the fields of public and global health continue to broaden toward planetary health, the SCDO is well poised to play a prominent role to decipher SCD pathophysiology further, and co-design diagnostics and therapeutics innovation in the field.

Identifiants

pubmed: 33021900
doi: 10.1089/omi.2020.0153
pmc: PMC7549008
doi:

Types de publication

Congress Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

559-567

Subventions

Organisme : NHLBI NIH HHS
ID : U24 HL135600
Pays : United States

Références

N Engl J Med. 2018 Apr 26;378(17):1583-1592
pubmed: 29694816
Genes (Basel). 2019 Nov 21;10(12):
pubmed: 31766582
Lancet Glob Health. 2014 Sep;2(9):e513-e520
pubmed: 25304418
Int Health. 2017 Sep 1;9(5):269-271
pubmed: 28911131
Diabetes Care. 2012 Feb;35(2):396-403
pubmed: 22210562
Front Genet. 2019 Oct 10;10:943
pubmed: 31649726
PLoS Med. 2013;10(7):e1001484
pubmed: 23874164
J Hypertens. 2007 Jun;25(6):1205-13
pubmed: 17563533
Lancet. 2017 Jun 17;389(10087):2355-2358
pubmed: 28635598
Lancet. 2013 Apr 27;381(9876):1469-77
pubmed: 23498849
Glob Heart. 2017 Jun;12(2):91-98
pubmed: 28302555
Lancet Diabetes Endocrinol. 2014 Jan;2(1):19-29
pubmed: 24622666
Pediatr Nephrol. 2018 Aug;33(8):1411-1417
pubmed: 29619552
PLoS Negl Trop Dis. 2013 May 30;7(5):e2120
pubmed: 23750287
Database (Oxford). 2019 Jan 1;2019:
pubmed: 31769834
Lancet. 2015 Nov 14;386(10007):1973-2028
pubmed: 26188744
Appl Transl Genom. 2016 Mar 15;9:23-9
pubmed: 27354937
Biol Blood Marrow Transplant. 2019 Oct;25(10):2103-2109
pubmed: 31229639
Br J Haematol. 2018 Sep;182(6):895-908
pubmed: 30027669
J Sex Med. 2019 Dec;16(12):1988-1999
pubmed: 31668730
Am J Med Genet A. 2018 Dec;176(12):2751-2759
pubmed: 30575291
J Diabetes. 2009 Sep;1(3):173-81
pubmed: 20923536
Blood Adv. 2018 Nov 30;2(Suppl 1):1-3
pubmed: 30504185
Pediatrics. 2017 Feb;139(2):
pubmed: 28126911
Lancet Haematol. 2020 Feb;7(2):e98-e99
pubmed: 32004491
Lancet. 2014 Mar 8;383(9920):847
pubmed: 24607088
OMICS. 2019 Mar;23(3):134-137
pubmed: 30822263
Lancet Diabetes Endocrinol. 2015 Jul;3(7):535-44
pubmed: 25957731
OMICS. 2019 Dec;23(12):623-630
pubmed: 31794294

Auteurs

Victoria Nembaware (V)

Division of Human Genetics, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Gaston K Mazandu (GK)

Division of Human Genetics, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Jade Hotchkiss (J)

Division of Human Genetics, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Jean-Michel Safari Serufuri (JM)

Division of Human Genetics, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Jill Kent (J)

Sickle Cell Programme, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania.

Andre Pascal Kengne (AP)

Non-Communicable Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa.

Kofi Anie (K)

London North West University Healthcare NHS Trust and Imperial College London, London, UK.
Sickle Cell Disease Genomics Network of Africa (SickleGenAfrica), University of Ghana, Accra, Ghana.

Nchangwi Syntia Munung (NS)

Division of Human Genetics, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Daima Bukini (D)

Sickle Cell Programme, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania.

Valentina Josiane Ngo Bitoungui (VJN)

Department of Microbiology, Hematology and Immunology, Faculty of Medicine and Pharmaceutical Sciences of the University of Dschang, Dschang, Cameroon.

Deogratias Munube (D)

Department of Paediatric and Child Health, Makerere University/Mulago National Referral Hospital, Kampala, Uganda.

Uzima Chirwa (U)

University Teaching Hospitals-Children's Hospital, University of Zambia, School of Medicine, Lusaka, Zambia.

Catherine Chunda-Liyoka (C)

University Teaching Hospitals-Children's Hospital, University of Zambia, School of Medicine, Lusaka, Zambia.

Agnes Jonathan (A)

Sickle Cell Programme, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania.

Miriam V Flor-Park (MV)

Onco-hematology Unit, Instituto da Criança, Hospital das Clínicas, Universidade de São Paulo, São Paulo, Brazil.

Kevin Kum Esoh (KK)

Department of Biochemistry, Faculty of Science, Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya.

Mario Jonas (M)

Division of Human Genetics, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Khuthala Mnika (K)

Division of Human Genetics, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Chandré Oosterwyk (C)

Division of Human Genetics, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Upendo Masamu (U)

Sickle Cell Programme, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania.

Jack Morrice (J)

Division of Human Genetics, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Annette Uwineza (A)

University of Rwanda, School of Medicine and Pharmacy, Kigali, Rwanda.

Arthemon Nguweneza (A)

Division of Human Genetics, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Kambe Banda (K)

Division of Human Genetics, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Isaac Nyanor (I)

Kumasi Centre for Sickle Cell Disease, Komfo Anokye Teaching Hospital, Accra, Ghana.

David Nana Adjei (DN)

Sickle Cell Disease Genomics Network of Africa (SickleGenAfrica), University of Ghana, Accra, Ghana.

Nathan Edward Siebu (NE)

Sickle Cell Disease Genomics Network of Africa (SickleGenAfrica), University of Ghana, Accra, Ghana.

Malula Nkanyemka (M)

Sickle Cell Programme, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania.

Patience Kuona (P)

University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.

Bamidele O Tayo (BO)

Department of Public Health Sciences, Parkinson School of Health Sciences and Public Health, Loyola University Chicago, Maywood, Illinois, USA.

Andrew Campbell (A)

Division of Hematology, Center for Cancer and Blood Disorders, Children's National Medical Center, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.

Assaf P Oron (AP)

Maternal, Newborn and Child Health, Institute for Disease Modeling, Bellevue, Washington, USA.

Obiageli E Nnodu (OE)

Centre of Excellence for Sickle Cell Disease Research and Training, University of Abuja, Abuja, Nigeria.

Vivian Painstil (V)

Department of Child Health, Komfo Anokye Teaching Hospital, Kumasi, Ghana.

Julie Makani (J)

Sickle Cell Programme, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania.

Nicola Mulder (N)

Computational Biology Division, Faculty of Health Sciences, Cape Town, South Africa.

Ambroise Wonkam (A)

Division of Human Genetics, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH